<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28100320</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1008-8830</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics</Title><ISOAbbreviation>Zhongguo Dang Dai Er Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Association of TLR3-1377C/T gene polymorphisms and expression with susceptibility to enterovirus 71 encephalitis in children].</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>43</EndPage><MedlinePgn>39-43</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the association of gene polymorphisms of Toll-like receptor 3 (TLR3)-1377C/T and expression of TLR3 with the susceptibility to enterovirus 71 (EV71) encephalitis in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 187 children with EV71 infection (59 children in the encephalitis group and 128 in the non-encephalitis group) and 232 children who underwent physical examination were enrolled in the case-control study. Polymerase chain reaction-restriction fragment length polymorphism was used to detect the TLR3-1377C/T gene polymorphisms. ELISA was used to measure the serum level of TLR3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no significant differences in the genotype and allele frequencies of TLR3-1377C/T between the non-encephalitis group and the encephalitis group. Compared with the control group, the encephalitis group and the non-encephalitis group had significant increases in the serum level of TLR3 (P&lt;0.05), and the non-encephalitis group had the highest level (P&lt;0.05). The encephalitis group had a significantly higher EV71 viral load than the non-encephalitis group (P&lt;0.01). The children aged &lt;1 year or &#x2265;1 year in the encephalitis group and the non-encephalitis group had significant increases in the serum level of TLR3 compared with their counterparts in the control group (P&lt;0.05), and the children aged &lt;1 year or &#x2265;1 year in the non-encephalitis group had a significantly higher serum level of TLR3 than those in the encephalitis group (P&lt;0.05). In the encephalitis group, the children aged &#x2265;1 year had a significantly higher TLR3 concentration than those aged &lt;1 year (P&lt;0.05), and there were no significant differences in the TLR3 concentration between the children aged &#x2265;1 year and &lt;1 year in the non-encephalitis group and the control group. In the encephalitis group, the proportion of children aged &lt;1 year was significantly higher than those aged &#x2265;1 year (P&lt;0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The TLR3-1377C/T gene polymorphisms are not significantly associated with the development of EV71 encephalitis. Low expression of TLR3 might weaken the inhibitory effect on virus replication and promote the development of EV71 encephalitis. The deficiency in the expression of TLR3 in serum after EV71 infection might be an important factor for the development of encephalitis in infants.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Ai-Yun</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Department of Neurological Rehabilitation, Qingdao Women and Children's Hospital, Qingdao University, Qingdao, Shandong 266034, China. drchen001@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Hong-Fang</ForeName><Initials>HF</Initials></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Fu-Yan</ForeName><Initials>FY</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pei-Pei</ForeName><Initials>PP</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jing-Fei</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zong-Bo</ForeName><Initials>ZB</Initials></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhongguo Dang Dai Er Ke Za Zhi</MedlineTA><NlmUniqueID>100909956</NlmUniqueID><ISSNLinking>1008-8830</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText Label="&#x76ee;&#x7684;">&#x7814;&#x7a76;Toll&#x6837;&#x53d7;&#x4f53;&#xff08;TLRs&#xff09;&#x57fa;&#x56e0;TLR3-1377C/T&#x4f4d;&#x70b9;&#x57fa;&#x56e0;&#x591a;&#x6001;&#x6027;&#x53ca;TLR3&#x8868;&#x8fbe;&#x6c34;&#x5e73;&#x4e0e;&#x513f;&#x7ae5;&#x80a0;&#x9053;&#x75c5;&#x6bd2;71&#x578b;&#xff08;EV71&#xff09;&#x8111;&#x708e;&#x6613;&#x611f;&#x6027;&#x4e4b;&#x95f4;&#x7684;&#x5173;&#x7cfb;&#x3002;</AbstractText><AbstractText Label="&#x65b9;&#x6cd5;">&#x6536;&#x96c6;EV71&#x611f;&#x67d3;&#x60a3;&#x513f;187&#x4f8b;&#xff08;&#x8111;&#x708e;&#x7ec4;59&#x4f8b;&#x548c;&#x65e0;&#x8111;&#x708e;&#x7ec4;128&#x4f8b;&#xff09;&#x4e0e;&#x540c;&#x671f;&#x5065;&#x5eb7;&#x4f53;&#x68c0;&#x513f;&#x7ae5;232&#x4f8b;&#x8fdb;&#x884c;&#x75c5;&#x4f8b;&#x5bf9;&#x7167;&#x7814;&#x7a76;&#x3002;&#x91c7;&#x7528;&#x805a;&#x5408;&#x9176;&#x94fe;&#x53cd;&#x5e94;&#x9650;&#x5236;&#x6027;&#x7247;&#x6bb5;&#x957f;&#x5ea6;&#x591a;&#x6001;&#x6027;&#xff08;PCR-RFLP&#xff09;&#x65b9;&#x6cd5;&#x5bf9;TLR3-1377C/T&#x57fa;&#x56e0;&#x591a;&#x6001;&#x6027;&#x8fdb;&#x884c;&#x68c0;&#x6d4b;&#xff0c;&#x91c7;&#x7528;ELISA&#x68c0;&#x6d4b;&#x8840;&#x6e05;TLR3&#x6c34;&#x5e73;&#x3002;</AbstractText><AbstractText Label="&#x7ed3;&#x679c;">&#x4e0e;EV71&#x611f;&#x67d3;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#x76f8;&#x6bd4;&#xff0c;&#x8111;&#x708e;&#x7ec4;TLR3-1377C/T&#x4f4d;&#x70b9;&#x57fa;&#x56e0;&#x578b;&#x5206;&#x5e03;&#x53ca;&#x7b49;&#x4f4d;&#x57fa;&#x56e0;&#x9891;&#x7387;&#x7684;&#x5dee;&#x5f02;&#x65e0;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i> &gt; 0.05&#xff09;&#x3002;&#x4e0e;&#x5bf9;&#x7167;&#x7ec4;&#x76f8;&#x6bd4;&#xff0c;EV71&#x611f;&#x67d3;&#x8111;&#x708e;&#x7ec4;&#x3001;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#x7684;&#x8840;&#x6e05;TLR3&#x6c34;&#x5e73;&#x5747;&#x663e;&#x8457;&#x589e;&#x9ad8;&#xff08;<i>P</i> &lt;0.05&#xff09;&#xff0c;&#x4ee5;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#x6700;&#x9ad8;&#xff08;<i>P</i> &lt;0.05&#xff09;&#x3002;&#x8111;&#x708e;&#x7ec4;&#x7684;EV71&#x75c5;&#x6bd2;&#x8f7d;&#x91cf;&#x9ad8;&#x4e8e;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#xff08;<i>P</i> &lt;0.01&#xff09;&#x3002;&lt;1&#x5c81;&#x6216; &#x2265; 1&#x5c81;&#x7684;EV71&#x611f;&#x67d3;&#x8111;&#x708e;&#x7ec4;&#x3001;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#x60a3;&#x513f;&#x7684;&#x8840;&#x6e05;TLR3&#x6c34;&#x5e73;&#x5747;&#x8f83;&#x76f8;&#x5e94;&#x5bf9;&#x7167;&#x7ec4;&#x589e;&#x9ad8;&#xff08;<i>P</i> &lt;0.05&#xff09;&#xff0c;&#x5176;&#x4e2d;&#x65e0;&#x8111;&#x708e;&#x7ec4;TLR3&#x6c34;&#x5e73;&#x9ad8;&#x4e8e;&#x76f8;&#x5e94;&#x5e74;&#x9f84;&#x7684;&#x8111;&#x708e;&#x7ec4;&#xff08;<i>P</i> &lt;0.05&#xff09;&#x3002;&#x8111;&#x708e;&#x7ec4;&#x2265;1&#x5c81;&#x60a3;&#x513f;&#x7684;TLR3&#x6d53;&#x5ea6;&#x9ad8;&#x4e8e;&lt;1&#x5c81;&#x8005;&#xff08;<i>P</i> &lt;0.05&#xff09;&#xff1b;&#x65e0;&#x8111;&#x708e;&#x7ec4;&#x53ca;&#x5bf9;&#x7167;&#x7ec4;&#x7684;TLR3&#x6d53;&#x5ea6;&#x5728;&lt;1&#x5c81;&#x6216;&#x2265;1&#x5c81;&#x60a3;&#x513f;&#x4e4b;&#x95f4;&#x7684;&#x5dee;&#x5f02;&#x65e0;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i> &gt; 0.05&#xff09;&#x3002;EV71&#x611f;&#x67d3;&#x8111;&#x708e;&#x7ec4;&#xff0c;&lt;1&#x5c81;&#x60a3;&#x513f;&#x6240;&#x5360;&#x6bd4;&#x4f8b;&#x9ad8;&#x4e8e; &#x2265; 1&#x5c81;&#x8005;&#xff08;<i>P</i> &lt;0.05&#xff09;&#x3002;</AbstractText><AbstractText Label="&#x7ed3;&#x8bba;">TLR3-1377C/T&#x4f4d;&#x70b9;&#x7684;&#x57fa;&#x56e0;&#x591a;&#x6001;&#x6027;&#x4e0e;EV71&#x8111;&#x708e;&#x7684;&#x53d1;&#x751f;&#x65e0;&#x660e;&#x663e;&#x76f8;&#x5173;&#x6027;&#x3002;TLR3&#x7684;&#x4f4e;&#x8868;&#x8fbe;&#x53ef;&#x80fd;&#x5bfc;&#x81f4;&#x5bf9;&#x75c5;&#x6bd2;&#x590d;&#x5236;&#x7684;&#x6291;&#x5236;&#x4f5c;&#x7528;&#x51cf;&#x5f31;&#xff0c;&#x4fc3;&#x8fdb;&#x4e86;EV71&#x8111;&#x708e;&#x7684;&#x53d1;&#x751f;&#x3002;&#x5a74;&#x513f;EV71&#x611f;&#x67d3;&#x540e;&#x8840;&#x6e05;TLR3&#x7684;&#x8868;&#x8fbe;&#x4e0d;&#x8db3;&#x53ef;&#x80fd;&#x662f;&#x5176;&#x5408;&#x5e76;&#x8111;&#x708e;&#x7684;&#x91cd;&#x8981;&#x56e0;&#x7d20;&#x3002;</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28100320</ArticleId><ArticleId IdType="pmc">PMC7390130</ArticleId><ArticleId IdType="pii">10.7499/j.issn.1008-8830.2016.12.005</ArticleId><ArticleId IdType="doi">10.7499/j.issn.1008-8830.2017.01.005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>&#x9093; &#x6167;&#x73b2;, &#x5f20; &#x7389;&#x51e4;. &#x80a0;&#x9053;&#x75c5;&#x6bd2;71&#x578b;&#x611f;&#x67d3;&#x81f4;&#x91cd;&#x75c7;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x65b0;&#x8ba4;&#x8bc6;. http://www.cnki.com.cn/Article/CJFDTOTAL-SYQK201122021.htm &#x4e2d;&#x534e;&#x5b9e;&#x7528;&#x513f;&#x79d1;&#x4e34;&#x5e8a;&#x6742;&#x5fd7;. 2016;31(10):736&#x2013;743.</Citation></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9(11):1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Liu XP, Li JA, et al. Correlation of an interleukin-4 gene polymorphism with susceptibility to severe enterovirus 71 infection in Chinese children. Arch Virol. 2015;160(4):1035&#x2013;1042. doi: 10.1007/s00705-015-2356-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-015-2356-8</ArticleId><ArticleId IdType="pubmed">25666199</ArticleId></ArticleIdList></Reference><Reference><Citation>Han ZL, Li JA, Chen ZB. Genetic polymorphism of CCL2-2510 and susceptibility to enterovirus 71 encephalitis in a Chinese population. Arch Virol. 2014;159(9):2503&#x2013;2507. doi: 10.1007/s00705-014-2082-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-014-2082-7</ArticleId><ArticleId IdType="pubmed">24788844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A, Li J, Liu P, et al. Association of interleukin-6-572C/G gene polymorphism and serum or cerebrospinal fluid interleukin-6 level with enterovirus 71 encephalitis in Chinese Han patients with hand, foot, and mouth disease. Inflammation. 2015;38(2):728&#x2013;735. doi: 10.1007/s10753-014-9983-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-014-9983-1</ArticleId><ArticleId IdType="pubmed">25081498</ArticleId></ArticleIdList></Reference><Reference><Citation>Land WG. The role of damage-associated molecular patterns in human diseases:Part I-promoting inflammation and immunity. http://cn.bing.com/academic/profile?id=4cd8b6f5f8be867c83a6c2745f731aac&amp;encoded=0&amp;v=paper_preview&amp;mkt=zh-cn. Sultan Qaboos Univ Med J. 2015;15(1):e9&#x2013;e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318613</ArticleId><ArticleId IdType="pubmed">25685392</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Molteni CG, Giliani S, et al. Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy children. Virol J. 2012;9:270. doi: 10.1186/1743-422X-9-270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-270</ArticleId><ArticleId IdType="pmc">PMC3511245</ArticleId><ArticleId IdType="pubmed">23151015</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang X, Shi Y, et al. Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China. Saudi J Gastroenterol. 2015;21(2):95&#x2013;103. doi: 10.4103/1319-3767.153832.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.153832</ArticleId><ArticleId IdType="pmc">PMC4392582</ArticleId><ArticleId IdType="pubmed">25843196</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x536b;&#x751f;&#x90e8;&#x624b;&#x8db3;&#x53e3;&#x75c5;&#x4e34;&#x5e8a;&#x4e13;&#x5bb6;&#x7ec4; &#x80a0;&#x9053;&#x75c5;&#x6bd2;71&#x578b;(EV71)&#x611f;&#x67d3;&#x91cd;&#x75c7;&#x75c5;&#x4f8b;&#x4e34;&#x5e8a;&#x6551;&#x6cbb;&#x4e13;&#x5bb6;&#x5171;&#x8bc6;. &#x4e2d;&#x534e;&#x513f;&#x79d1;&#x6742;&#x5fd7;. 2011;49(9):675&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantt S, Yao L, Kollmann TR, et al. Implications of age-dependent immune responses to enterovirus 71 infection for disease pathogenesis and vaccine design. J Pediatric Infect Dis Soc. 2013;2(2):162&#x2013;170. doi: 10.1093/jpids/pit017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/pit017</ArticleId><ArticleId IdType="pubmed">26619463</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JA, Chen ZB, Lv TG, et al. Genetic polymorphism of CCL2-2518, CXCL10-201, IL8+781 and susceptibility to severity of Enterovirus-71 infection in a Chinese population. Inflamm Res. 2014;63(7):549&#x2013;556. doi: 10.1007/s00011-014-0724-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0724-6</ArticleId><ArticleId IdType="pubmed">24609754</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Cao RY, Deng YQ, et al. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol J. 2011;8:106. doi: 10.1186/1743-422X-8-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-106</ArticleId><ArticleId IdType="pmc">PMC3060144</ArticleId><ArticleId IdType="pubmed">21385398</ArticleId></ArticleIdList></Reference><Reference><Citation>Carty M, Reinert L, Paludan SR, et al. Innate antiviral signalling in the central nervous system. Trends Immunol. 2014;35(2):79&#x2013;87. doi: 10.1016/j.it.2013.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2013.10.012</ArticleId><ArticleId IdType="pubmed">24316012</ArticleId></ArticleIdList></Reference><Reference><Citation>Daffis S, Samuel MA, Suthar MS, et al. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol. 2008;82(21):10349&#x2013;10358. doi: 10.1128/JVI.00935-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00935-08</ArticleId><ArticleId IdType="pmc">PMC2573187</ArticleId><ArticleId IdType="pubmed">18715906</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. Update on enterovirus 71 infection. Curr Opin Virol. 2014;5:98&#x2013;104. doi: 10.1016/j.coviro.2014.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC, Wark PA. Innate immunity and immune evasion by entrovirus 71. Viruses. 2015;7(12):6613&#x2013;6630. doi: 10.3390/v7122961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Shih SR. Strategies to develop antivirals against enterovirus 71. Virol J. 2013;10:28. doi: 10.1186/1743-422X-10-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-28</ArticleId><ArticleId IdType="pmc">PMC3614426</ArticleId><ArticleId IdType="pubmed">23339605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok CC. Therapeutic and prevention strategies against human enterovirus 71 infection. World J Virol. 2015;4(2):78&#x2013;95. doi: 10.5501/wjv.v4.i2.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v4.i2.78</ArticleId><ArticleId IdType="pmc">PMC4419123</ArticleId><ArticleId IdType="pubmed">25964873</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>